Liver transplantation for hepatocellular carcinoma: The Japanese experience

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 5, 2010, Pages 533-538

  Furukawa, Hiroyuki ^a   Shimamura, Tsuyoshi ^a   Suzuki, Tomomi ^a   Taniguchi, Masahiko ^a   Nakanishi, Kazuaki ^a   Yamashita, Kenichiro ^a   Kamiyama, Toshiya ^a   Matsushita, Michiaki ^a   Todo, Satoru ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Living donor liver transplantation; Pretransplant treatment; Proposed criteria

Indexed keywords

DECARBOXYPROTHROMBIN;

ARTICLE; CANCER MORPHOLOGY; CANCER SURVIVAL; CHEMOEMBOLIZATION; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MEDICAL ETHICS; PATIENT SELECTION; RECURRENCE RISK; TREATMENT OUTCOME; TUMOR ABLATION; TUMOR VOLUME; LIVER TUMOR; MORTALITY; REVIEW; STATISTICS;

CARCINOMA, HEPATOCELLULAR; HUMANS; JAPAN; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; TREATMENT OUTCOME;

EID: 79952109507     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0168-5     Document Type: Article

References (12)

1. Umemura T, Ichijo T, Yoshizawa K, et al. Epidemiology of hepatocellular carcinoma in Japan. J Gastroenterol. 2009;44(Suppl 19):102-7.
2. Takada Y, Ito T, Ueda M, et al. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria. Dig Dis. 2007;25(4):299-302. (Pubitemid 350014956)
3. Taketomi A, Sanefuji K, Soejima Y, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation. 2009;87(4):531-7.
4. Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis. 2007;25(4):310-2. (Pubitemid 350014958)
5. Todo S, Furukawa H, Tada M. Extending indication: role of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl. 2007;13(11 Suppl 2):S48-54.
6. Ito T, Takada Y, Ueda M, et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl. 2007;13(12):1637-44.
7. Taketomi A, Soejima Y, Yoshizumi T, et al. Liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2008;15(2):124-30. (Pubitemid 351516969)
8. Soejima Y, Taketomi A, Yoshizumi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation. 2007;83(7):893-9. (Pubitemid 46682729)
9. Lo CM, Fan ST, Liu CL, et al. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl. 2004;10(3):440-7.
10. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693-9. (Pubitemid 26079803)
11. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33(6):1394-403. (Pubitemid 32496976)
12. Takada Y, Ueda M, Ito T, et al. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl. 2006;12(6):912-9. (Pubitemid 43960366)